control group:Placebo + telmisartan tablet

2 trials

Sponsors

Xiyuan Hospital, China Academy of Chinese Medical Sciences

Conditions

IgA nephropathy

Unknown Phase

Study on dose-effect relationship and safety of Modified Huangqi Chifeng Decoction with different doses of Astragalus in the treatment of IgA nephroproteinuria

Active, not recruitingITMCTR2000004074

Xiyuan Hospital, China Academy of Chinese Medical SciencesIgA nephropathy

Start: 2020-11-15Updated: 2023-02-20

Study on dose-effect relationship and safety of Modified Huangqi Chifeng Decoction with different doses of Astragalus in the treatment of IgA nephroproteinuria

Active, not recruitingChiCTR2000040161

Xiyuan Hospital, China Academy of Chinese Medical SciencesIgA nephropathy

Start: 2020-11-15Updated: 2021-01-18